These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 17171193)
1. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants. van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ; Drugs Today (Barc); 2006 Nov; 42(11):741-54. PubMed ID: 17171193 [TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants. van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ; Timely Top Med Cardiovasc Dis; 2007 Feb; 11():E7. PubMed ID: 17380217 [TBL] [Abstract][Full Text] [Related]
3. Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Reijmer YD; van den Berg E; de Bresser J; Kessels RP; Kappelle LJ; Algra A; Biessels GJ; Diabetes Metab Res Rev; 2011 Feb; 27(2):195-202. PubMed ID: 21294241 [TBL] [Abstract][Full Text] [Related]
4. Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia. Kwon KJ; Lee EJ; Kim MK; Kim SY; Kim JN; Kim JO; Kim HJ; Kim HY; Han JS; Shin CY; Han SH Neurobiol Dis; 2015 Jan; 73():12-23. PubMed ID: 25281785 [TBL] [Abstract][Full Text] [Related]
5. [Cognitive dysfunction and dementia associated with elderly diabetes]. Kouta Y; Sakurai T; Yokono K Nihon Rinsho; 2006 Jan; 64(1):119-23. PubMed ID: 16408458 [TBL] [Abstract][Full Text] [Related]
6. Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus. Bruehl H; Wolf OT; Sweat V; Tirsi A; Richardson S; Convit A Brain Res; 2009 Jul; 1280():186-94. PubMed ID: 19463794 [TBL] [Abstract][Full Text] [Related]
7. Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome. Borshchev YY; Uspensky YP; Galagudza MM Life Sci; 2019 Nov; 237():116932. PubMed ID: 31606384 [TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: A systematic comparison of their impact on cognition. van den Berg E; Kloppenborg RP; Kessels RP; Kappelle LJ; Biessels GJ Biochim Biophys Acta; 2009 May; 1792(5):470-81. PubMed ID: 18848880 [TBL] [Abstract][Full Text] [Related]
9. Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Biessels GJ; Reijmer YD Diabetes; 2014 Jul; 63(7):2244-52. PubMed ID: 24931032 [TBL] [Abstract][Full Text] [Related]
10. Cognitive dysfunction in patients with type 2 diabetes. Reijmer YD; van den Berg E; Ruis C; Kappelle LJ; Biessels GJ Diabetes Metab Res Rev; 2010 Oct; 26(7):507-19. PubMed ID: 20799243 [TBL] [Abstract][Full Text] [Related]
11. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Verdelho A; Madureira S; Moleiro C; Ferro JM; Santos CO; Erkinjuntti T; Pantoni L; Fazekas F; Visser M; Waldemar G; Wallin A; Hennerici M; Inzitari D; Neurology; 2010 Jul; 75(2):160-7. PubMed ID: 20625169 [TBL] [Abstract][Full Text] [Related]
12. Cognitive dysfunction and diabetes: implications for primary care. Biessels GJ; Kerssen A; de Haan EH; Kappelle LJ Prim Care Diabetes; 2007 Dec; 1(4):187-93. PubMed ID: 18632044 [TBL] [Abstract][Full Text] [Related]
13. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. de Bresser J; Reijmer YD; van den Berg E; Breedijk MA; Kappelle LJ; Viergever MA; Biessels GJ; Dement Geriatr Cogn Disord; 2010; 30(5):381-6. PubMed ID: 20962529 [TBL] [Abstract][Full Text] [Related]
14. Mid-life predictors of cognitive impairment and dementia in type 2 diabetes mellitus: the Fremantle Diabetes Study. Bruce DG; Davis WA; Starkstein SE; Davis TM J Alzheimers Dis; 2014; 42 Suppl 3():S63-70. PubMed ID: 24840567 [TBL] [Abstract][Full Text] [Related]
15. Diabetes, Obesity, and the Brain: New Developments in Biobehavioral Medicine. Everson-Rose SA; Ryan JP Psychosom Med; 2015; 77(6):612-5. PubMed ID: 26163814 [TBL] [Abstract][Full Text] [Related]
16. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Kalaria RN Nutr Rev; 2010 Dec; 68 Suppl 2(Suppl 2):S74-87. PubMed ID: 21091952 [TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Barnes DE; Alexopoulos GS; Lopez OL; Williamson JD; Yaffe K Arch Gen Psychiatry; 2006 Mar; 63(3):273-9. PubMed ID: 16520432 [TBL] [Abstract][Full Text] [Related]
18. Heritability and genetic association analysis of neuroimaging measures in the Diabetes Heart Study. Raffield LM; Cox AJ; Hugenschmidt CE; Freedman BI; Langefeld CD; Williamson JD; Hsu FC; Maldjian JA; Bowden DW Neurobiol Aging; 2015 Mar; 36(3):1602.e7-15. PubMed ID: 25523635 [TBL] [Abstract][Full Text] [Related]
19. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models. Calvo-Ochoa E; Arias C Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982 [TBL] [Abstract][Full Text] [Related]
20. Aggravated cognitive and brain functional impairment in mild cognitive impairment patients with type 2 diabetes: a resting-state functional MRI study. Zhou X; Zhang J; Chen Y; Ma T; Wang Y; Wang J; Zhang Z J Alzheimers Dis; 2014; 41(3):925-35. PubMed ID: 24705547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]